Search
News Chat
Login
Search
Top
For You
Business
Crypto
Culture
Environment
Politics
Science
Sports
Tech
Video Games
World
Casgevy News
Top stories
FDA Approves Casgevy, First CRISPR Therapy for Sickle Cell Disease, Priced at $2.2 Million
Authors
4
12 days
Bio
Science
CRISPR Gene Therapies Show Promise for Rare Diseases but Face Accessibility Challenges
Authors
5
11 days
Economics
Business
Prediction markets for Casgevy
Prediction markets for Casgevy
Will Casgevy, the first cell therapy using CRISPR gene editing, have net sales >$100M in 2024?
Dec 15, 7:21 PM
Feb 16, 4:59 AM
25%
chance
6
96
Option
Votes
YES
NO
160
83
Will a gene therapy that edits multiple genes using CRISPR be approved by the FDA before 2030?
Jan 26, 12:13 AM
Jan 1, 7:59 AM
75.26%
chance
24
1005
Option
Votes
NO
YES
1080
953
Articles
Latest stories
CRISPR Gene Therapies Show Promise for Rare Diseases but Face Accessibility Challenges
Authors
5
11 days
Economics
Business
FDA Approves Casgevy, First CRISPR Therapy for Sickle Cell Disease, Priced at $2.2 Million
Authors
4
12 days
Bio
Science
FDA Announces Casgevy Approval, CAR-T Fast Track Designation, T Cell Malignancy Risk, and Novartis Admonishment
Authors
15
5 months
Bio
Science
FDA Approves Casgevy, a Vertex-CRISPR Therapy, for Beta Thalassemia
Authors
12
6 months
Bio
Science
FDA Approves Bluebird Bio's Lyfengia with Black Box Warning; Vertex's Casgevy Priced at $2.2 Million, Shares Plunge 42%
Authors
4
7 months
Economics
Business
NIH Pauses Stroke Drug Trial, HIV Vaccine Trials Halted in Africa
Authors
5
7 months
Economics
Business
Previous
Next
